Comparison of Multigam IV (5% vs. 10%) in Patients With an Immunodeficiency Secondary to a Hematological Disorder
CompletedOBSERVATIONAL
Enrollment
30
Participants
Timeline
Start Date
June 30, 2017
Primary Completion Date
October 31, 2017
Study Completion Date
December 13, 2017
Conditions
Hematologic DiseasesSecondary Immune Deficiency
Trial Locations (1)
3000
UZ Leuven Gasthuisberg, Leuven
All Listed Sponsors
lead
Universitaire Ziekenhuizen KU Leuven
OTHER
NCT03250845 - Comparison of Multigam IV (5% vs. 10%) in Patients With an Immunodeficiency Secondary to a Hematological Disorder | Biotech Hunter | Biotech Hunter